Next Article in Journal
Anticonvulsant and Sedative-Hypnotic Activities of N-Acetyl / Methyl Isatin Derivatives
Previous Article in Journal
First Total Synthesis of Ergosta-5,8-dien-3β-ol Erste Totalsynthese von Ergosta-5,8-dien-3β-ol
Article Menu

Article Versions

Export Article

Open AccessArticle
Sci. Pharm. 2008, 76(4), 605-620; doi:10.3797/scipharm.0807-20 (registering DOI)

QSAR Study on Novel CCR5 Receptor Antagonists: An Insight into the Structural Requirement for the HIV Co Receptor Antagonist Activity

Department of Pharmaceutical Chemistry, School of Pharmacy, Addis Ababa University, P.O. Box 1176, Addis Ababa, Ethiopia
Received: 28 July 2008 / Accepted: 28 October 2008 / Published: 1 November 2008
Download PDF [258 KB, uploaded 28 December 2016]

Abstract

Chemokines receptors have emerged as important drug targets for development of agents against the HIV/AIDS pandemic. With the purpose of designing new chemical entities with enhanced antagonistic potencies against the CCR5 chemokine receptor, the QSAR study carried out on 70 novel phenoxybenzyl derivatives as antagonists of CCR5 HIV co receptor is presented. The developed model was validated by standard QSAR parameters and through a detailed structural analysis on how it reproduces the quantitative differences observed in the experimentally known activity data. The model showed a good correlative and predictive ability having a cross validated correlation co-efficient (r2cv) of 0.708 and a conventional correlation coefficient (r2) was found to be 0.805. The study revealed that the CCR5 antagonistic activity exhibited by the series is largely explained by steric factors of substituents emphasizing the role of size and shape of the inhibitors in making effective antagonist-CCR5 binding chemistry. A detailed investigation was made on the structural basis for the antiretroviral activity and the insights gleaned from the study could be usefully employed to design antagonists with a much more enhanced potency and selectivity.
Keywords: QSAR; HIV/AIDS; CCR5; Phenoxybenzyls; TSAR QSAR; HIV/AIDS; CCR5; Phenoxybenzyls; TSAR
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

DESSALEW, N. QSAR Study on Novel CCR5 Receptor Antagonists: An Insight into the Structural Requirement for the HIV Co Receptor Antagonist Activity. Sci. Pharm. 2008, 76, 605-620.

Show more citation formats Show less citations formats

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Sci. Pharm. EISSN 2218-0532 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top